Key result
Various physiological, dietary, pharmacological, and hormonal agents can induce the browning of white adipose tissue, offering potential therapeutic strategies for treating type 2 diabetes.
Why the study?
The browning of white fat to recruit beige adipose tissue affects whole-body energy metabolism, glucose homeostasis, and insulin sensitivity, making it relevant to type 2 diabetes.
Recruitment of beige adipocytes through various browning agents presents a promising therapeutic avenue for managing type 2 diabetes and metabolic disorders.
Caution against clinical adoption in T2D; leaves open human translation of browning agents.
Mammalian adipose tissue is traditionally categorized into white and brown relating to their function and morphology: while white serves as an energy storage, brown adipose tissue acts as the heat generator maintaining the core body temperature. The most recently identified type of fat, beige adipocyte tissue, resembles brown fat by morphology and function but is developmentally more related to white. The synthesis of beige fat, so-called browning of white fat, has developed into a topical issue in diabetes and metabolism research. This is due to its favorable effect on whole-body energy metabolism and the fact that it can be recruited during adult life. Indeed, brown and beige adipose tissues have been demonstrated to play a role in glucose homeostasis, insulin sensitivity, and lipid metabolism-all factors related to pathogenesis of type 2 diabetes. Many agents capable of initiating browning have been identified so far and tested widely in humans and animal models including in vitro and in vivo experiments. Interestingly, several agents demonstrated to have browning activity are in fact secreted as adipokines from brown and beige fat tissue, suggesting a physiological relevance both in beige adipocyte recruitment processes and in maintenance of metabolic homeostasis. The newest findings on agents driving beige fat recruitment, their mechanisms, and implications on type 2 diabetes are discussed in this review.
No takes yet. Share an insight, caveat, or question.
Kaisanlahti et al. (2018) conducted a review in Type 2 diabetes. Browning agents was evaluated. Various physiological, dietary, pharmacological, and hormonal agents can induce the browning of white adipose tissue, offering potential therapeutic strategies for treating type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: